ASSOCIATION OF THE VLA-ALPHA-6 SUBUNIT WITH A NOVEL PROTEIN - A POSSIBLE ALTERNATIVE TO THE COMMON VLA-BETA-1 SUBUNIT ON CERTAIN CELL-LINES
- 15 April 1989
- journal article
- research article
- Vol. 264 (11), 6529-6535
Abstract
On platelets and other cell types, VLA-6 is a typical integrin heterodimer, with .alpha.6-.beta.1 subunit association. However, on colon carcinoma cell lines and other epithelial cells the .alpha.6 subunit associates with a novel protein (called .beta.4) rather than the VLA .beta.1 subunit. The .beta.4 protein differs from .beta.1 because (i) it is not recognized by anti-.beta.1 antibodies, (ii) it yields different V8 protease cleavage products, (iii) it has a more limited cell distribution, (iv) it has multiple forms, each larger in size than .beta.1, and (v) it is susceptible to protease digestion which does not effect .beta.1. Although different in many respects, the .beta.4 subunit does have partial N-terminal sequence similarity to the already defined integrin .beta.1, .beta.2, and .beta.3 subunits. The presence of .alpha.6-.beta.4 complexes was demonstrated by coprecipitation of .beta.4 with an anti-.alpha.6 antibody and by covalent cross-linking experiments. Although .alpha.6-.beta.4 complexes were present on certain cells, other VLA .alpha. subunits on those same cells remained associated with the VLA .beta.1 subunit to form typical VLA heterodimers (e.g. VLA-1, VLA-2, VLA-3). By the criteria of N-terminal amino acid sequencing, antibody recognition, V8 peptide maps, and reduced/nonreduced gel migration, the .alpha.6 subunit which associates with .beta.4 appears identical to the .alpha.6 associated with the VLA .beta.1 subunit on platelets and other cell types. The .beta.4 subunit may be of major importance because (i) it is highly abundant on the surface of colon carcinoma cell lines, and (ii) it is highly immunogenic relative to other surface proteins.This publication has 33 references indexed in Scilit:
- Development of mouse mammary gland: identification of stages in differentiation of luminal and myoepithelial cells using monoclonal antibodies and polyvalent antiserum against keratin.Journal of Histochemistry & Cytochemistry, 1986
- A monoclonal antibody cibr17 recognizes a myoepithelium‐specific antigen in human mammary glandInternational Journal of Cancer, 1986
- CYTOTOXIC MURINE MONOCLONAL-ANTIBODY LAM8 WITH SPECIFICITY FOR HUMAN SMALL CELL-CARCINOMA OF THE LUNG1986
- Biochemical characterization of VLA-1 and VLA-2. Cell surface heterodimers on activated T cells.Journal of Biological Chemistry, 1985
- Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines.The Journal of Immunology, 1984
- Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.Proceedings of the National Academy of Sciences, 1984
- Monoclonal Antibodies Specific for Rat IgG1, IgG2a, and IgG2b Subclasses, and Kappa Chain Monotypic and Allotypic Determinants: Reagents for Use with Rat Monoclonal AntibodiesHybridoma, 1982
- ANALYSIS OF SURFACE-PROTEINS OF MOUSE LUNG CARCINOMAS USING MONOCLONAL-ANTIBODIES1981
- DISTRIBUTION OF A TUMOR-CELL SURFACE PROTEIN COMMON TO SEVERAL MURINE LUNG CARCINOMAS .2.1980
- Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.Journal of Biological Chemistry, 1977